Patent ID: 9567369
Date: 2017-02-14
CPC Classifications: A61P,C07K,C12N

Claim:
1. A method of treating glioblastoma, breast cancer, fibrosarcoma, prostate cancer, and melanoma, comprising the step of administering an effective amount of an isolated therapeutic Cystatin C peptide of 16 amino acids, consisting of a peptide sequence selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22 and SEQ ID NO:23 to a metastatic cancer patient, wherein the tumor burden is reduced, and wherein the therapeutic Cystatin C peptide is attached to an uptake peptide.